On Thursday, August 26, 2021, Takeda Pharmaceutical Company Limited announced the decision to suspend the use of certain lots of Moderna's COVID-19 Vaccine for intramuscular injection because it received reports of foreign matter in unpunctured vials for a particular lot. It was found that the Moderna's Vaccine being suspected of contamination with foreign particle matter was administered to GU students and staff from August 9 through 20 as part of the workplace vaccination campaign.

1. Lot Number Suspected of Contamination (administered on campus)

3004667 ("Lot number" can be confirmed by your record of vaccinations)

2. Period of Vaccination/Number of Vials Used

Period of Vaccination: From Monday, August 9 through Friday, August 20, 2021

Number of Vials Used: 600 (approximately 6,000 doses)

In time of vaccinations, pharmacists checked all the vials before every injection, and no foreign particles or any abnormalities were suspected, and no health hazards have been reported so far stemming from these injections.

The Ministry of Health, Labor and Welfare of Japan and Takeda Pharmaceutical Company stated that they have not received any safety concerns or complaints from the public over vaccinations, but if you are worried about your physical conditions (realizing that you were administered the doses with the lot number above), please contact:

(1) Call Center of Takeda Pharmaceutical Company Limited

Tel: 0120-793-056 (from 9:00a.m. to 5:30p.m. excluding weekends, holidays and non-business days)

(2) Health Administration Center or your family doctor if you suspect your symptoms may have something to do with the injections you received.

We will swiftly cope with any medical issues arising among GU students and staff in close contact with the Ministry of Health, Labor and Welfare and Takeda Pharmaceutical Company. Thank you for your understanding.